16 February 2011 18:34 [Source: ICIS news]
SAN DIEGO, ?xml:namespace>
Donen’s initial focus will be on moving Rivertop’s first commercial product, glucaric acid, from lab into higher volume productions, the company said on the sidelines of the Next Generation Bio-Based Chemicals Summit in
The company initially plans to use its glucaric acid as a cost-competitive replacement for phosphates and citrates in the global detergent market, it said.
Donen recently served as director of process development and engineering at Segetis, another bio-based industrial materials firm.
Previously, he worked as director of manufacturing technology and engineering with NatureWorks and as global technology manager for Dow Chemical’s polystyrene (PS) business in
Donen worked with Rivertop CEO Jim Stoppert at all three companies.
“Steve’s expertise will allow us to effectively scale our green chemistry platform, while maintaining the cost efficiencies and product performance we’ve proven in our lab,” said Stoppert.
Donen, meanwhile, said he recognised Montana-based Rivertop as having a “quick pathway to commercialisation and market success”.
The Bio-Based Chemicals Summit runs through Thursday.
To discuss issues facing the chemical industry go to ICIS connect
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|